Further, much of our focus was on the specific immune programming effects of t-dEVs on the lungs due to the role of IRF5 as a transcription factor that mediates immune activation and recruitment of tumor infiltrating lymphocytes7,99,100. This evidence concerns the gene IRF5 and neoplasm.